水野和幸 (Kazuyuki Mizuno) - マイポータル

基本情報

所属: 名古屋大学医学部附属病院化学療法部病院助教

J-GLOBAL ID: 202401016178366504
researchmap会員ID: R000070021

論文

Risk factors for decreased bone mineral density in patients with metabolic dysfunction-associated steatotic liver disease: A cross-sectional study at a health examination center

Yokoyama S, Honda T, Ishizu Y, Imai N, Ito T, Yamamoto K, Mizuno K, Kojima T, Kariya N, Nakamura M …

Clinical Nutrition 43(6) 1425-1432 2024年6月
Outcomes of immune checkpoint inhibitor-induced liver toxicity managed by hepatologists in a multidisciplinary toxicity team

Ito, T, Mizuno, K, Yamamoto, T, Yasuda, T, Yokoyama, S, Yamamoto, K, Imai, N, Ishizu, Y, Honda, T, Hama, M …

HEPATOLOGY RESEARCH 2024年4月4日
特集肝疾患-診療のチェックポイント2023 第Ⅰ部診断のチェックポイント第5章肝疾患鑑別診断のチェックポイント 1.薬物性肝障害が疑われるとき

伊藤隆徳, 山本崇文, 水野和幸, 石上雅敏, 川嶋啓揮

臨床消化器内科 38(7) 799-806 2023年6月9日
Abdominal pain accompanied by elevated serum inflammatory markers and biliary enzymes for diagnosing immune checkpoint inhibitor-induced sclerosing cholangitis

Yamamoto, T, Mizuno, K, Ito, T, Yokoyama, S, Yamamoto, K, Imai, N, Ishizu, Y, Honda, T, Ishikawa, T, Kanamori, A …

INVESTIGATIONAL NEW DRUGS 41(3) 512-521 2023年6月
Serum osteopontin predicts the response to atezolizumab plus bevacizumab in patients with hepatocellular carcinoma

Yamauchi, R, Ito, T, Yoshio, S, Yamamoto, T, Mizuno, K, Ishigami, M, Kawashima, H, Yasuda, S, Shimose, S, Iwamoto, H …

JOURNAL OF GASTROENTEROLOGY 58(6) 565-574 2023年6月
Pretreatment Proteinuria Predicts the Prognosis of Patients Receiving Systemic Therapy for Unresectable Hepatocellular Carcinoma

Mizuno, K, Imai, N, Yamamoto, T, Yokoyama, S, Yamamoto, K, Ito, T, Ishizu, Y, Honda, T, Kuzuya, T, Ishigami, M …

CANCERS 15(10) 2023年5月21日
Clustering using unsupervised machine learning to stratify the risk of immune-related liver injury

Yamamoto, T, Morooka, H, Ito, T, Ishigami, M, Mizuno, K, Yokoyama, S, Yamamoto, K, Imai, N, Ishizu, Y, Honda, T …

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 38(2) 251-258 2023年2月
A case of antiprogrammed death-ligand 1 antibody-induced multisystem immune-related adverse events with pancreatitis and steroid-resistant sclerosing cholangitis

Yamamoto, T, Ito, T, Mizuno, K, Shinya, Y, Yamamoto, K, Imai, N, Ishizu, Y, Honda, T, Kawashima, H, Matsui, T …

JOURNAL OF DIGESTIVE DISEASES 23(7) 404-409 2022年7月
Immune-related Liver Injury is a Poor Prognostic Factor in Patients with Nonsmall Cell Lung Cancer Treated with Immune Checkpoint Inhibitors

Yamamoto, T, Ito, T, Hase, T, Ishigami, M, Mizuno, K, Yamamoto, K, Imai, N, Ishizu, Y, Honda, T, Shibata, H …

CANCER INVESTIGATION 40(2) 189-198 2022年2月7日
Clinical course of liver injury induced by immune checkpoint inhibitors in patients with advanced malignancies

Ito, T, Ishigami, M, Yamamoto, T, Mizuno, K, Yamamoto, K, Imai, N, Ishizu, Y, Honda, T, Kawashima, H, Yasuda, S …

HEPATOLOGY INTERNATIONAL 15(5) 1278-1287 2021年10月
Bioinformatics and Functional Analyses Implicate Potential Roles for EOGT and L-fringe in Pancreatic Cancers

Barua, R, Mizuno, K, Tashima, Y, Ogawa, M, Takeuchi, H, Taguchi, A, Okajima, T

MOLECULES 26(4) 2021年2月
Real world data of liver injury induced by immune checkpoint inhibitors in Japanese patients with advanced malignancies

Mizuno, K, Ito, T, Ishigami, M, Ishizu, Y, Kuzuya, T, Honda, T, Kawashima, H, Inukai, Y, Toyoda, H, Yokota, K …

JOURNAL OF GASTROENTEROLOGY 55(6) 653-661 2020年6月
Dynamic Evaluation of Liver Fibrosis to Assess the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis C Who Achieved Sustained Virologic Response

Toyoda, H, Tada, T, Yasuda, S, Mizuno, K, Ito, T, Kumada, T

CLINICAL INFECTIOUS DISEASES 70(6) 1208-1214 2020年3月15日
The emergence of non-hypervascular hypointense nodules on enhanced MRI in patients with chronic hepatitis C

Toyoda, H, Tada, T, Yasuda, S, Mizuno, K, Sone, Y, Kaneoka, Y, Maeda, A, Akita, T, Tanaka, J, Kumada, T

ALIMENTARY PHARMACOLOGY & THERAPEUTICS 50(11-12) 1232-1238 2019年12月
IMPACT OF PRETREATMENT COMPENSATED CIRRHOSIS OR A HISTORY OF CURATIVELY TREATED HCC ON THE MORTALITY OF PATIENTS WITH HCV AFTER SVR BY DAA REGIMENS

Toyoda, H, Yasuda, S, Mizuno, K, Kumada, T

HEPATOLOGY 70 984A-984A 2019年10月
The course of elderly patients with persistent hepatitis C virus infection without hepatocellular carcinoma

Mizuno, K, Toyoda, H, Yasuda, S, Tada, T, Kumada, T, Sone, Y, Tanaka, J

JOURNAL OF GASTROENTEROLOGY 54(9) 829-836 2019年9月
Influence of renal dysfunction on dose reduction and virologic efficacy of regimens combining ribavirin and all-oral direct acting antivirals in patients with chronic hepatitis C virus infection

Nakashima, M, Toyoda, H, Tada, T, Mizuno, K, Iio, E, Tanaka, Y, Sugiyama, T, Yoshimura, T, Kumada, T

HEPATOLOGY RESEARCH 49(5) 512-520 2019年5月
The impact of HCV eradication by direct-acting antivirals on the transition of precancerous hepatic nodules to HCC: A prospective observational study

Toyoda, H, Kumada, T, Tada, T, Mizuno, K, Sone, Y, Akita, T, Tanaka, J, Johnson, PJ

LIVER INTERNATIONAL 39(3) 448-454 2019年3月
Impact of hepatocellular carcinoma aetiology and liver function on the benefit of surveillance: A novel approach for the adjustment of lead-time bias

Toyoda, H, Kumada, T, Tada, T, Mizuno, K, Hiraoka, A, Tsuji, K, Ishikawa, T, Akita, T, Tanaka, J

LIVER INTERNATIONAL 38(12) 2260-2268 2018年12月
Impact of previously cured hepatocellular carcinoma (HCC) on new development of HCC after eradication of hepatitis C infection with non-interferon-based treatments

Toyoda, H, Kumada, T, Tada, T, Mizuno, K, Sone, Y, Kaneoka, Y, Maeda, A, Akita, T, Tanaka, J

ALIMENTARY PHARMACOLOGY & THERAPEUTICS 48(6) 664-670 2018年9月

もっとみる

共同研究・競争的資金等の研究課題

網羅的遺伝子解析によるirAE肝障害発症メカニズムの探索および治療アルゴリズムの開発

科学研究費助成事業基盤研究(C) 2023年4月 - 2026年3月

水野和幸